BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, March 16, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 17, 2018
View Archived Issues
Total surveillance leads to cell division atlas
Read More
Mutations in IRF2BPL causes neurodegeneration in humans and flies
Read More
ASD diagnosis branches out
Read More
Cancer immunotherapy could get metabolic leg up
Read More
FDA approves Ajovy for preventive treatment of migraine
Read More
AstraZeneca adopts Horizon Discovery's Edit-R crRNA libraries for genomics discovery platform
Read More
Efgartigimod phase II data in ITP support progression to phase III development
Read More
Azitra, The Jackson Laboratory awarded grant to identify compounds for treatment of skin infections
Read More
Glenmark to use Mitra's CANscript platform in support of immuno-oncology pipeline
Read More
CymaBay opens enrollment in phase III study of seladelpar for primary biliary cholangitis
Read More
Palobiofarma enrolling patients in phase I study of PBF-1129 for NSCLC
Read More
Gilead Sciences and Precision BioSciences collaborate to develop therapies against HBV
Read More
MaxCyte studies MCY-M11 in phase I for advanced ovarian cancer and peritoneal mesothelioma
Read More
Zhejiang Beta Pharma patents fibroblast growth factor receptor inhibitors
Read More
AbbVie presents novel optimized GABA-B PAMs with efficacy in animal models of seizure
Read More
DGMIF presents DN-200434 for ATC radioiodine therapy improvement
Read More
Strategic alliance between Bayer and Evotec results in the discovery of BAY-2395840
Read More
Targeting alpha-4 integrin alleviates allergic conjunctivitis in animal models
Read More
First phase I data presented for inhaled pirfenidone
Read More
Bristol-Myers Squibb initiates two phase III trials of BMS-986165 in plaque psoriasis
Read More
Integrin alphaVbeta6 PET tracer shows promise for assessment of interstitial lung disease
Read More
Phase II data presented for CFTR potentiator QBW-251
Read More
